[1]
K. C. Selvan, K. Teerapuncharoen, and R. Bag, “Oral Pulmonary Arterial Hypertension-Targeted Therapy in Patients With Pulmonary Hypertension due to Interstitial Lung Disease”, J Clin Med Res, vol. 17, no. 3, pp. 153–163, Mar. 2025, doi: 10.14740/jocmr6164.